Responses
8. Towards novel therapeutic strategies
Retreatment of rheumatoid arthritis patients with 1×1000 mg rituximab results in sustained clinical response in clinical responders initially treated with 2×1000 mg rituximab
Compose a Response to This Article
Other responses
No responses have been published for this article.